Insider Transactions in Q3 2023 at Verrica Pharmaceuticals Inc. (VRCA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 24
2023
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+33.29%
|
-
|
|
Aug 24
2023
|
Gary Goldenberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.81%
|
-
|
|
Aug 24
2023
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+32.34%
|
-
|
|
Aug 24
2023
|
Ted White PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+26.9%
|
-
|
|
Aug 24
2023
|
Terry Kohler CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+50.0%
|
-
|
|
Jul 24
2023
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
33,789
-29.2%
|
$135,156
$4.83 P/Share
|
|
Jul 24
2023
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
38,262
-37.88%
|
$153,048
$4.83 P/Share
|
|
Jul 24
2023
|
Gary Goldenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,699
-29.04%
|
$114,796
$4.83 P/Share
|
|
Jul 24
2023
|
Ted White PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,677
-28.24%
|
$202,708
$4.83 P/Share
|
|
Jul 24
2023
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
200,000
+2.48%
|
$1,000,000
$5.02 P/Share
|
|
Jul 21
2023
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+46.36%
|
-
|
|
Jul 21
2023
|
Joe Bonaccorso CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+49.75%
|
-
|
|
Jul 21
2023
|
Gary Goldenberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+43.15%
|
-
|
|
Jul 21
2023
|
Ted White PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+45.53%
|
-
|